Analysts are estimating that Medpace Hldgs will report an earnings per share (EPS) of $2.80.
Anticipation surrounds Medpace Hldgs's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
Historical Earnings Performance
The company's EPS beat by $0.21 in the last quarter, leading to a 18.27% drop in the share price on the following day.
Here's a look at Medpace Hldgs's past performance and the resulting price change:
Quarter
Q2 2024
Q1 2024
Q4 2023
Q3 2023
EPS Estimate
2.54
2.46
2.22
2.04
EPS Actual
2.75
3.20
2.46
2.22
Price Change %
-18.0%
8.0%
12.0%
20.0%
Medpace Hldgs Share Price Analysis
Shares of Medpace Hldgs were trading at $342.89 as of October 17. Over the last 52-week period, shares are up 55.27%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
Analysts' Perspectives on Medpace Hldgs
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Medpace Hldgs.
The consensus rating for Medpace Hldgs is Neutral, derived from 10 analyst ratings. An average one-year price target of $395.6 implies a potential 15.37% upside.
Comparing Ratings with Peers
The analysis below examines the analyst ratings and ...
